Unit 1: Comprehensive Guide to the Immune System

1. Introduction to the Immune System

The immune system is a complex network of cells, tissues, organs, and molecules that work cooperatively to protect the body against foreign pathogens, such as bacteria, viruses, fungi, and parasites, while distinguishing them from the body's own healthy cells.

Types of Immunity: Innate and Adaptive

Immunity is broadly classified into two interconnected arms: Innate (non-specific) immunity and Adaptive (specific) immunity.

Clonal Selection Theory

The Clonal Selection Theory explains how the immune system can respond to an immense diversity of antigens using a pre-existing pool of lymphocytes, each carrying unique antigen receptors.

The process of clonal selection operates through the following steps:

1. Generation of Diversity: Before meeting any antigen, progenitor cells produce millions of unique B and T lymphocytes, each carrying a single type of membrane receptor with unique specificity. This occurs via random genetic recombination.
2. Clonal Deletion (Self-Tolerance): Immature lymphocytes that bind strongly to self-antigens are destroyed or inactivated during development. This prevents autoimmune reactions.
3. Antigen Binding and Activation: When a foreign antigen enters the body, it selectively binds to the specific lymphocyte that carries the complementary receptor.
4. Clonal Expansion: Once activated, this single lymphocyte undergoes rapid mitotic division, producing a large population of genetically identical cells (a clone).
5. Differentiation: The cloned cells differentiate into two functional subsets:

• Effector Cells: Active cells (such as plasma cells secreting antibodies, helper T cells, and cytotoxic T cells) that immediately work to eliminate the antigen.
• Memory Cells: Long-lived, inactive cells that persist in the body to provide rapid protection upon re-exposure to the same antigen.

Primary and Secondary Immune Responses

The nature of the adaptive immune response changes significantly upon subsequent exposures to the same pathogen.

2. Components of the Immune System: Molecules, Cells, and Organs

Molecules of the Immune System

The coordination of the immune response relies heavily on several classes of signaling and recognition molecules:

• Cytokines: Small, soluble proteins released by cells that act as chemical messengers to mediate and regulate immunity, inflammation, and hematopoiesis (such as Interleukins, Interferons, and Tumor Necrosis Factors).
• Chemokines: A subgroup of cytokines that specifically direct the migration of immune cells (chemotaxis) to sites of infection or injury.
• Major Histocompatibility Complex (MHC): Cell-surface glycoproteins that present antigen peptides to T cells. Class I MHC is present on all nucleated cells, while Class II MHC is found primarily on antigen-presenting cells (APCs).
• Complement Proteins: A group of plasma proteins that circulate in an inactive state but, when activated, cascade to assist (complement) antibodies in destroying pathogens via opsonization, inflammation, and membrane lysis.

Cells of the Immune System

Immune cells originate from pluripotent hematopoietic stem cells in the bone marrow and differentiate along two main lineages: myeloid and lymphoid.

• Myeloid Lineage (Primarily Innate Immunity):

• Neutrophils: The most abundant white blood cells; highly phagocytic and first responders to acute bacterial infections.
• Macrophages: Tissue-resident phagocytes derived from blood monocytes. They engulf debris, kill pathogens, and act as professional antigen-presenting cells (APCs).
• Dendritic Cells: Specialized APCs with star-like projections. They capture antigens in peripheral tissues and migrate to lymphoid organs to activate naive T cells, acting as a crucial bridge between innate and adaptive immunity.
• Mast Cells and Basophils: Cells rich in histamine granules; key mediators of allergic reactions and defense against parasites.
• Eosinophils: Granulocytes specialized in combating multicellular parasitic infections and participating in allergic responses.

• Lymphoid Lineage (Primarily Adaptive Immunity):

• B Lymphocytes (B Cells): Programmed to produce antibodies. When activated, they differentiate into antibody-secreting plasma cells and memory B cells.
• T Lymphocytes (T Cells): Mediators of cellular immunity. They express T-cell receptors (TCRs) and are divided into: Helper T Cells (CD4⁺) which help orchestrate the immune response by secreting cytokines that activate other immune cells, and Cytotoxic T Cells (CD8⁺) which directly target and destroy virus-infected cells and tumor cells.
• Natural Killer (NK) Cells: Large granular lymphoid cells that belong to the innate system. They identify and kill virus-infected and tumor cells that have lost Class I MHC expression.

Organs of the Immune System

Lymphoid organs are categorized into primary (central) and secondary (peripheral) lymphoid organs based on their role in lymphocyte development and activation.

3. Antigens: Immunogenicity, Antigenicity, and Allied Concepts

Basic Properties of Antigens

An antigen is any substance that can bind specifically to components of the immune system, such as antibodies or T-cell receptors (TCRs).

Antigens contain specific structural regions recognized by immune receptors, known as epitopes or antigenic determinants. Epitopes can be linear (sequential amino acids) or conformational (brought together by three-dimensional folding).

Antigenicity vs. Immunogenicity

Although often used interchangeably, these terms represent distinct biological concepts:

• Immunogenicity: The capacity of a substance to induce a de novo immune response (humoral and/or cell-mediated) in a host. Every immunogen is an antigen.
• Antigenicity: The ability of a substance to combine specifically with the final products of an immune response (antibodies or TCRs). Not every antigen is an immunogen.

Haptens

A hapten is a small, non-immunogenic substance that possesses antigenicity but lacks immunogenicity on its own.

Because of their small molecular size and simple chemical structure, haptens cannot initiate an immune response independently. However, if a hapten is covalently bound to a large, immunogenic carrier protein, the resulting complex becomes immunogenic. The immune system will then generate antibodies against the hapten, the carrier protein, and the junction between them.

Clinical Example: Penicillin is a small molecule (hapten) that is not immunogenic on its own. In some individuals, penicillin binds to red blood cell membrane proteins (acting as carrier proteins), forming an immunogenic hapten-carrier complex that can trigger severe allergic reactions (anaphylaxis).

Adjuvants

An adjuvant is a substance that, when mixed with an antigen and injected with it, enhances the immunogenicity of that antigen without forming a permanent chemical bond with it.

Adjuvants do not confer immunogenicity on haptens, but they boost the response to substances that are already immunogenic. They work through several mechanisms: prolonging antigen persistence at the injection site (the 'depot effect'), enhancing co-stimulatory signals by activating local antigen-presenting cells through pattern recognition receptors, and inducing local inflammation, which recruits lymphocytes and APCs to the site.

Example: Alum (aluminum hydroxide or aluminum phosphate) is a widely used adjuvant in human vaccines.

Superantigens

A superantigen is a class of viral or bacterial toxins that can activate a massive, non-specific population of T cells, bypassing the standard antigen-processing and presentation pathway.

Mechanism of Action:

• Normal Antigen Presentation: A standard antigen is processed into peptides by APCs and presented inside the peptide-binding cleft of Class II MHC. It activates only those T cells whose TCRs are highly specific to that particular peptide (about 0.001% to 0.01% of the T-cell pool).
• Superantigen Binding: A superantigen does not undergo processing. Instead, it binds directly to the outside of the Class II MHC molecule and the variable beta domain (V_β) of the TCR.
• This cross-linking bypasses the specificity requirement, binding to and activating up to 20% of all T cells in the body simultaneously.

Consequence: This massive, polyclonal T-cell activation triggers an uncontrolled, systemic release of inflammatory cytokines (such as IL-2, IFN-γ, and TNF-α), leading to systemic inflammatory response syndrome, capillary leak, hypotension, shock, and potentially multi-organ failure.

Clinical Example: Toxic Shock Syndrome Toxin-1 (TSST-1) secreted by Staphylococcus aureus.

4. Antibodies (Immunoglobulins): Structure, Classes, and Interactions

Basic Structure of an Antibody

Antibodies, or immunoglobulins (Ig), are glycoprotein molecules produced by plasma cells. The basic functional unit is a Y-shaped structure composed of four polypeptide chains: two identical Heavy (H) chains (large polypeptides) and two identical Light (L) chains (small polypeptides). These chains are linked together by covalent interchain disulfide (-S-S-) bonds and non-covalent interactions.

Each heavy and light chain contains:

• Variable (V) Region: Located at the amino-terminal (N-terminal) ends of the Y-arms. The variable region of one light chain (V_L) and one heavy chain (V_H) pair up to form the antigen-binding site (paratope). Each monomeric antibody has two identical antigen-binding sites.
• Constant (C) Region: Located at the carboxy-terminal (C-terminal) ends. The constant region of the heavy chains determines the class (isotype) of the antibody and mediates effector functions.

Proteolytic digestion of an antibody yields distinct fragments:

• Fab (Fragment antigen-binding): Two identical fragments produced by papain cleavage, each containing one complete light chain and the V_H and C_H1 domains of one heavy chain. Fab fragments retain antigen-binding capacity but cannot activate effector functions.
• Fc (Fragment crystallizable): One fragment consisting of the remaining constant domains of the heavy chains. It is responsible for binding to Fc receptors on immune cells and activating the classical complement pathway.
• Hinge Region: A flexible segment of the heavy chains that allows the two Fab arms to move dynamically, facilitating binding to epitopes spaced at varying distances.

Classes of Antibodies

There are five primary classes (isotypes) of immunoglobulins in mammals, determined by the type of heavy chain present: μ (mu) for IgM, δ (delta) for IgD, γ (gamma) for IgG, α (alpha) for IgA, and ε (epsilon) for IgE. Light chains are of two types: κ (kappa) or λ (lambda).

Effector Functions of Antibodies

Antibodies do not directly destroy pathogens; instead, they bind to antigens and trigger various clearing mechanisms:

• Neutralization: Antibodies bind to viral surface proteins or bacterial toxins, blocking their ability to bind to and infect host cells.
• Opsonization: Pathogens coated with IgG antibodies are easily recognized and engulfed by phagocytes (neutrophils and macrophages) that express Fcγ receptors.
• Complement Activation: IgM or IgG bound to a pathogen surface undergoes conformational changes that trigger the classical complement pathway, leading to the formation of the Membrane Attack Complex (MAC) and cell lysis.
• Antibody-Dependent Cellular Cytotoxicity (ADCC): IgG coats target cells (such as infected cells or tumor cells). Natural Killer (NK) cells bind to the Fc region of these antibodies via CD16 (FcγRIII) receptors, triggering the release of perforin and granzymes to induce apoptosis in the target cell.
• Agglutination: Multivalent antibodies (especially IgM) cross-link multiple particulate antigens (like bacteria or red blood cells), clumping them together to facilitate phagocytosis.

Antigen-Antibody Interactions: Affinity and Avidity

The binding between an antigen's epitope and an antibody's paratope involves non-covalent interactions (such as hydrogen bonds, electrostatic interactions, Van der Waals forces, and hydrophobic interactions). This binding is reversible.

Two essential parameters describe the strength of these interactions:

Affinity: The thermodynamic measure of the binding strength between a single antigen-binding site (paratope) of an antibody and a single epitope of an antigen.

It is represented by the association constant (K_a) at equilibrium:

K_a = [Ab-Ag] / ([Ab] × [Ag])

High affinity means tight binding, which is less likely to dissociate.

Avidity: The overall cooperative binding strength of an antibody-antigen complex containing multiple binding sites.

While affinity refers to a single site, avidity is the functional synergy of all antigen-binding sites working together. It is determined by the intrinsic affinity of individual binding sites, the valence of both the antibody (number of binding arms, such as 2 for IgG, 10 for pentameric IgM) and the antigen (number of identical epitopes), and the structural arrangement of the interacting components.

Key Observation: Pentameric IgM has lower intrinsic affinity for individual epitopes compared to mature IgG (which has undergone affinity maturation). However, because IgM has a high valency (10 binding sites), its overall avidity for a multivalent antigen is extremely high, allowing it to bind pathogens very effectively during early stages of infection.